Targeting therapies influence survival of refractory patients with advanced lung adenocarcinoma: A phase II randomized trial.

7599 Background: Several attempts were undertaken in order to improve outcome of the standard platinum based chemotherapy by adding new targeting therapies. Methods: 174 patients with lung adenocar...